Liquidia (LQDA) Profit After Tax (2020 - 2026)
Liquidia (LQDA) posted quarterly Profit After Tax of $52.9 million for Q1 2026, up 237.78% year-over-year from $15.6 million in Q1 2025, and up 262.66% quarter-over-quarter from $14.6 million in Q4 2025.
Liquidia (LQDA) Profit After Tax (2020 - 2026) Analysis & Trends
Liquidia's Profit After Tax history runs 7 years deep, the most recent figure standing at $52.9 million for Q1 2026.
- In Q1 2026, Profit After Tax rose 237.78% year-over-year to $52.9 million; the TTM figure through Mar 2026 stood at $22.3 million (up 116.35% YoY), while the FY2025 annual figure was -$68.9 million, up 46.28% from the prior year.
- Profit After Tax for Q1 2026 stood at $52.9 million, up from $14.6 million in the prior quarter.
- The five-year high for Profit After Tax was $52.9 million in Q1 2026, with the low at -$41.6 million in Q2 2025.
- The 5-year median for Profit After Tax is -$15.9 million (2022), against an average of -$15.5 million.
- The sharpest annual moves came in 2023 and 2026: Profit After Tax sank 320.17% in 2023, then surged 237.78% in 2026.
- Liquidia's Profit After Tax stood at -$6.5 million in 2022, then tumbled by 320.17% to -$27.4 million in 2023, then tumbled by 40.32% to -$38.5 million in 2024, then jumped by 137.84% to $14.6 million in 2025, then surged by 262.66% to $52.9 million in 2026.
- Business Quant data shows LQDA's Profit After Tax at $52.9 million in Q1 2026, $14.6 million in Q4 2025, and -$3.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | 710.56 Mn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Liquidia | 6.52 Bn | 6.23 Bn | 160.92 Mn | 74.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 74.72 Mn |
| Mar 31, 2026 | 52.86 Mn |
| Dec 31, 2025 | 14.58 Mn |
| Sep 30, 2025 | -3.53 Mn |
| Jun 30, 2025 | -41.58 Mn |
| Mar 31, 2025 | -38.37 Mn |
| Dec 31, 2024 | -38.52 Mn |
| Sep 30, 2024 | -31.03 Mn |
| Jun 30, 2024 | -28.67 Mn |
| Mar 31, 2024 | -30.08 Mn |
| Dec 31, 2023 | -27.45 Mn |
| Sep 30, 2023 | -15.79 Mn |
| Jun 30, 2023 | -23.52 Mn |
| Mar 31, 2023 | -11.75 Mn |
| Dec 31, 2022 | -6.53 Mn |
| Sep 30, 2022 | -9.09 Mn |
| Jun 30, 2022 | -9.45 Mn |
| Mar 31, 2022 | -15.94 Mn |
| Dec 31, 2021 | -11.56 Mn |
| Sep 30, 2021 | -7.28 Mn |